Two Sigma Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Two Sigma Investments's MDGL Position: Q3 2026 in Review
Two Sigma Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 32,682% in Q3 2026, buying an estimated $97.8M and bringing the position to 185,547 shares worth $93.5M. The position accounts for 0.07% of the portfolio, ranked #338.
Two Sigma Investments first reported a position in MDGL in Q4 2013 and has held it in 16 quarters since. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Two Sigma Investments held 185,547 shares of Madrigal Pharmaceuticals worth $93.5M as of Q3 2026.
- Two Sigma Investments bought 184,981 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $97.8M.
- Madrigal Pharmaceuticals made up 0.07% of Two Sigma Investments's portfolio in Q3 2026, its #338 holding.
- Two Sigma Investments first reported a position in Madrigal Pharmaceuticals in Q4 2013 and has held it in 16 quarters since.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.